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 Spleen cells from mice bearing solid Ehrlich tumor stimu-
lated in vitro with Ehrlich-tumor extract or with PHA, IL-2 
and tumor extract were transferred i.v. in mice-bearers of 
small transplanted Ehrlich tumor (Group I) and in tumor-
free mice, followed by tumor transplantation (Group II). 
Morphological findings for antitumor effect were found in 
tumors of 42.5% of experimental mice. Four criteria were 
established in this respect, including evidence for 
lymphocytic cytotoxity. Production of a factor inhibiting 
Ehrlich ascites-cell migration was found in a migration-
inhibition assay from the stimulated spleen cells and spleen 
cells obtained from mice of Group I and II. The indirect 
data suggested that the transferred stimulated spleen cells 
(lymphocytes) propagated in lymphoid organs, particularly 
in the spleen of mice. Then T-cells, especially tumor-specific 
cytotoxic lymphocytes, migrated by circulation into the pe-
riphery of the tumor nodule and influenced on tumor cells. 
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proved to be an appropriate model for investigation of 
the effect of adoptively transferred sensitized spleen 
cells. It is important for immunotherapy against the 
neoplasm to detect morphological findings connected 
with antitumor effect of transferred spleen cells stimu-
lated with immunogenic Ehrlich-tumor extract. 
 The purpose of this study was to determine the 
morphological evidence suggesting for antitumor ef-
fect against transplanted solid Ehrlich tumors in mice 
in which spleen cells, obtained from Ehrlich-tumor 
bearing mice and stimulated with Ehrlich extract 




 inbred male %'_157B1_/6 mice, 10-12 weeks old, were 
obtained from the production colonies of the 
Bulgarian Academy of Science and were used in ex-
periments according to the Institutional Guidelines of 
Pleven University School of Medicine.
Introduction
 It has been shown that Ehrlich tumor can grow in 
almost any mouse strain in an ascitic or solid tumor, 
across histocompatibility barriers"", as it lacks H-2 
antigens". On the other hand, Ehrlich cells possess an-
tigens recognized as foreign in mice, which provoke 
an immune response after s.c. but not after i.p. inocu-
lation of the living tumor cells". Subiza et al.2 ' re-
ported that a nonspecific suppressor cell population 
(splenic natural suppressor cells) had been developed 
in the spleen of mice bearing solid Ehrlich tumor. 
 The transplanted solid Ehrlich tumor in mice
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Tumors and tumor-bearing mice
 Solid Ehrlich tumor was established by s.c. inocula-
tion of Ehrlich ascites tumor cells (2 x 107) in the back of 
mice, and was maintained by serial s.c. transplantation 
of small pieces of tumor in mice. Animals carrying 
solid transplanted Ehrlich tumor of the 3rd to 8th pas-
sage generations were used. Ehrlich ascites tumor was 
maintained by serial i.p. transplantation (1 x 10' cells) 
every 10 days in intact tumor-free mice.
Spleen cell suspensions
 The spleen cell suspensions were prepared in RPMI 
1640 (GIBCO) supplemented with 5% FCS, 2 mM L-
glutamine, penicillin (100 U/ml) and streptomycin 
(100 ug/ml). The aseptically removed spleens from 
mice-bearers of growing tumors were pressed between
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two sterile slides, and, after filtration, the spleen cells 
were freed of erythrocytes by treatment with Tris-
buffered 0.83% ammonium chloride (pH 7.2). The sus-
pensions were incubated in plastic flasks at 37°C for 
35 min., and then were adjusted to a final concentra-
tion of 4 x 10 6 cells/ml. A T-lymphocytes- rich fraction 
was obtained by passing spleen cell suspensions 
through a nylon wool column.
Preparation of an Ehrlich-tumor extract and stimulation 
of the spleen cells with it
  Tumor extract was obtained by using an extraction 
procedure as it was described previously','). Briefly, 
ten milliliters of cold 3 M KCL in PBS (pH 7.2) was 
added to every 1 g of tissue of solid Ehrlich tumor for 
16 hr. The mixture was centrifuged at 40,000 x g for 
1 hr at 4°C. Further centrifugation of the mixture at 
18,000 x g was also done. The supernatants were dia-
lyzed against PBS, and the protein content was ad-
justed to 0.30-0.40 mg protein/ml. Samples of 0.4 ml 
of spleen cell suspension, each containing 8 x 10 5 cells 
(2 x 10'/ml) were mixed with 80p 1 of Ehrlich extract 
and incubated for 24 hr at 37V in a 5% C02 atmos-
phere. The mixture in approximately 1/10 of the total 
number of samples were centrifuged at 18,000 x g for 
20 min at 4°C. The supernatants were decanted and 
then prepared for examination of migration inhibition 
activity as was described previously". The remaining 
samples were centrifuged at 400 x g for 1 0 min to 
preserve viability of the cells. The supernatants were 
decanted, passed through 0.45 fn m filters and investi-
gated for migration inhibition, too. The spleen cells 
were harvested, washed and suspended in HBSS. 
 Complex stimulation of spleen cells was carried out 
in 24 flat-bottom well plates (Linbro, Flow Laboratories). 
Spleen cell suspensions containing 8 x 10 5 cells in 0.4 
ml of each well were supplemented with PHA (1% 
v/v); 0.5 ml of the medium was added and incubated 
for 48 hr at 37 °C in a humid atmosphere of 5% CO2. 
After the incubation with PHA a supernatant contain-
ing T-cell growth factor (IL-2), 50% v/v, was added, 
approximately 10 U IL-2 in each well with 8 x 10' 
cells. This supernatant was obtained from spleen cells 
of exbreeder mice (1 x 10 6 cells/ml) stimulated with 
PHA (2,ug/ml) for 48 hr, and then depleted of PHA 
using chicken erythrocytes". After 4 days of culture 
the procedure was continued by adding the extract of 
solid Ehrlich tumor of 80,u1 to wells for 24 hr. The su-
pernatants were decanted and after filtration were as-
sayed for migration inhibition. The cells were har-
vested, washed in HBSS and prepared for inoculation 
in mice.
Assessment of migration inhibition
 Samples of 0.2 ml of Ehrlich ascites tumor cells (2 x 
10' /ml), suspended in RPMI 1640 supplemented with 
5% fetal calf serum and antibiotics were mixed with 
0.1 ml of the supernatants of spleen cells stimulated 
as was indicated above, or not stimulated. The mix-
tures were incubated for 2 hr at 37V in an atmos-
phere of 5% CO2. Capillary tubes sealed at one end 
were filled with Ehrlich cells, and centrifuged at 250 
x g. The portions with sedimented cells were cut off, 
placed in chambers filled with medium and incubated 
at 37°C for 24 hr. The areas of Ehrlich-cell migration 
were projected and measured by planimetry. The mi-
gration index (MgI) was calculated according -to the 
following formula:
       Average area of migration of Ehrlich cells 
       incubated --with--the--supernatant 
Average area of migration of Ehrlich cells 
       incubated without the supernatant 
 Fraction of responding (positive) cultures (FrRCs) 
was calculated as number of responding cultures per 
total number of cultures. Cultures were designated as 
responding (positive) when the supernatants obtained 
from them show an inhibition effect (IE) against 
Ehrlich-cell migration (MgI<0.80). For example, FrRCs 
is 0.8 (8/10) in the presence of 8 responding (positive) 
cultures).
Inoculation of spleen cells in mice and formation of 
experimental groups 
 The stimulated spleen cells from tumor-bearing mice 
were concentrated in HBSS at 20-25 x 10' cells/ml. 
Seventy animals were divided in three groups. In 
Group I the stimulated spleen cells were transferred 
by one or two i.v. injections through the tail vein in 
mice, bearing a small Ehrlich tumor, and in Group II 
in tumor-free mice in which the transplantation of 
tumor was accomplished 7-8 days after the inocula-
tion. Twenty mice were in each group. According the 
preliminary experiments, the mice of Group I and II 
were treated predominantly with 35-40 x 10' stimu-
lated spleen cells; ten mice-with 50-55 x 10' cells. 
Previously, doses of 20-25 x 10' cells were used, too. 
The mice of Group I were sacrificed by cervical dislo-
cation after a mean term of 22.40±3.09 days of stimu-
lated spleen cell transfer (34.86±4.13 days of tumor 
transplantation), and these of Group II- 34.45 ± 4.62 
days after spleen cell transfer (27.85 ± 4.15 days of 
transplantation). Additionally, ten tumor-bearing mice 
treated with 35-40 x 106 stimulated spleen cells were 
killed within three to six days after the cell transfer.
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As controls (Group III) were used 20 tumor-bearing 
mice untreated by transfer of stimulated spleen cells.
Histological examination
 Small tissue slices were fixed in 10% neutral 
formalin (pH 7.0) for 24 hr and embedded in paraffin. 
Deparaffinized sections 4 urn thick were stained by 
using the following procedures: hematoxylin and eosin 
(H&E), v. Gieson, Feulgen for DNA, methylgreen 
pyronin for RNA, PAS (Hotchkiss). The mitotic count 
was performed on H&E stained sections in the most 
mitotically active areas". High-power fields, limited by 
restrictive screen at 200 um x 200 um, were investi-
gated by a Carl Zeiss microscope (Germany). Mitotic 
index (MI) was calculated as the number of mitoses 
per number of counted tumor cells x 100. The 
apoptosis, which is a mode of cell death, was estab-
lished by the apoptotic cells and bodies. They were 
counted, in tumor slices stained with H&E and 
Feulgen. High-power fields, limited as is shown above, 
were randomly selected. The apoptotic index (AI) was 
assessed as a number of apoptotic cells and bodies per 
number of counted tumor cells x 100. Two thousand 
tumor cells were counted for determination the mi-
totic and the apoptotic index. 
 The reactive changes in the T- and B-cell regions of 
spleens and lymph nodes of the mice were graded in 
three degrees (I-III) according to their size, cell activity 
and cell transformation.
Staining of cells in the smears and electron microscopy 
 Smears from sediments were stained by the Giemsa 
method and by methylgreen pyronin for RNA. For 
electron microscopic examination pieces of tumor 
were fixed with 1.6% glutaraldehyde in 0.1 M phos-
phate buffered saline (pH 7.4) at 4°C for 2 hr and with 
2.5% for 1 hr, postfixed in 1 % osmium tetroxide, dehy-
drated with ethanol and embedded in Durcupan 
(Fluka AG). Ultrathin sections were stained with 
uranyl acetate and lead citrate, and were investigated 
with an electron microscope Tesla B-500.
Statistics 
 Statistical analysis was performed by using the 
Student's t test, chi-square test and by determing of 
the correlation coefficient. The significance of differ-
ence between the compared groups was defined with 
the Mann-Whitney U test. P<0.05 was considered to 
be significant for the two-tailed test.
Results
Morphological changes in the transplanted solid Ehrlich 
tumors suggestive for antitumor effect
 In mice bearers of solid Ehrlich tumor treated with 
stimulated spleen cells we described morphological 
changes related to the suppression of growth and ex-
tension of tumor, death of tumor cells (apoptosis and 
necrosis) and tumor regression. On the basis of these 
morphological changes we described four criteria for 
antitumor effect (a.e.) against the transplanted tumor 
of mice treated with stimulated spleen cells as follows: 
1) Evidence of a small tumor nodule without exten-
sion in surrounding tissues usually with central zone 
of necrosis, and preserved tumor cells peripherally 
showing decrease of their proliferation and an activity 
of apoptosis. 2) Infiltration of the periphery of tumors 
with lymphocytes and a few plasmocytes which was 
complete, continuous, engaging entire circumference of 
tumor nodule, or incomplete. 3) Invasion of immune 
lymphocytes among tumor cells with histological and 
ultrastructural data for lymphocytic cytotoxity. 4) 
Formation of a fibrous capsule in the periphery of 
tumor between the cells of infiltrate. 
 Morphological findings in the transplanted solid 
Ehrlich tumor, suggesting for a.e., were found in 42.5% 
of mice of Group I and II treated by transfer of stimu-
lated spleen cells (7 from 20 in Group I and 10 from 
20 in Group II). In mice with such an effect small 
tumor nodule was found to be as big as grain lentil or 
pea, one was larger (5 x 6 mm). Histologically, tumor 
nodules were limited. Usually, around the area of ne-
crosis tumor tissue was detected, sized between 250 
p m and 600,u m wide, and rarely - 800,u m. It was 
composed mainly of mononuclear cells with pale nu-
clei, but in some tumors numerous cells with 
hyperchromatic nuclei were found, as well as giant 
mono- and multinuclear cells in the proximity of ne-
crosis. Infiltrate rich in lymphocytes and mixed with 
a few plasmocytes and macrophages was established 
in the periphery of the tumor (Fig. 1), and partially in-
vaded tumor tissue. This infiltrate was mainly con-
tinuous (complete) or, more rarely, incomplete engag-
ing the half or two thirds of the circumference of the 
tumor nodule. Small blood vessels, often augmented in 
number, were found in this area (Fig. 2). Tumor cells 
in apoptosis and apoptotic bodies were observed 
among the invading lymphocytes and between pre-
served tumor cells (Fig. 3). Focuses of necrosis were 
detected in proximity to the lymphocytic infiltrate. 
The fibrous capsule formed in the periphery of tumor 
was mainly complete i.e. in the entire circumference of 
tumor, or incomplete. Evidence of proliferation of
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Figure 1. Small limited tumor nodule with continuous 
lymphocytic infiltrate in its periphery. (H&E, x 50). Ehrlich 
tumor in a mouse of Group I with findings for a.e.
fibroblasts and formation of collagen fibers and their 
condensation among the infiltrate of lymphocytes 
were found, including by the ultrastructural examina-
tion. 
 Four mice of Group II did not show a development 
of a tumor after the transplantation. In one mouse of 
Group I, bearing a small tumor and also treated with 
stimulated spleen cells, thirty days after transplanta-
tion the tumor had completely regressed. 
 The data for a.e. in the transplanted tumor showed 
almost identical rate of cases among the mice treated 
with doses of 35 x 10' to 55 x 10' stimulated spleen 
cells. The previously examined doses of 20-25 x 10' 
proved to be with a low effectivity.
Morphological changes in the transplanted solid Ehrlich 
tumors without findings for antitumor effect
 In these mice (13 in Group I and 10 in Group II), 
also treated with stimulated spleen cells like the mice 
with effect in the transplanted tumor and survived for 
the same periods, tumors were detected with the fol-
lowing sizes: 0.5 x 1-1.5 cm, 1.5 x 2.5 cm. Histologically, 
the tumors were found to infiltrate the adjacent tis-
sues. Peripheral cell infiltrate rich in lymphocytes oc-
cupying as a tight strip from one third to half of the 
circumference of the tumor nodule was found in less 
than the half of the cases, but without evidence for 
lymphocytic cytotoxicity. An incomplete capsule was 
detected in a few tumors.
Figure 2. Cell infiltrate rich in lymphocytes in the periph-
ery of tumor nodule. Small blood vessels (arrows) appeared 
among the infiltrate. (H&E, x 100). Ehrlich tumor in a mouse 
of Group II with findings for a.e.
Morphological changes in the transplanted solid Ehrlich 
tumors in untreated mice
 The tumor-bearing mice untreated by transfer of 
stimulated spleen cells (Group III, controls) killed in 
the identical term of survival after transplantation as 
in mice of Group I and II showed tumors sized 1 x 1.5 
cm, 1.5 x 2.5 cm and rarely 3 x 4 cm. Histologically, 
the tumor displayed a solid growth pattern and infil-
trated fibrotic, adipose and muscle tissue. Fields of ne-
crosis were found among the growing tumor tissue 
and in central region of tumor. Scanty infiltrate of 
lymphocytes together with formation of a partial cap-
sule was detected in the periphery of the tumor only 
in two cases, but no morphological evidence for 
lymphocytic cytotoxicity was found.
Figure 3. Lymphocytes from peripheral infiltrate partially 
invading tumor tissue. Apoptotic cells with compaction of 
nuclear chromatin and apoptotic bodies are observed (ar-
rows). (H&E, x 100). Ehrlich tumor in a mouse of Group I 
with findings for a.e.
Mitosis and apoptosis
 Mitotic rate and apoptosis of tumor cells at the time 
of killing of the mice, expressed by mean value of MI 
and AI, are shown in Table 1. The mean MI in solid
Table 1. Mitotic rate and apoptosis in transplanted solid 
Ehrlich tumors of mice
Groups Mitotic Index (MI) Apoptotic Index (AI) 
----------------------------------------------------------------------
      Tumors with Tumors without Tumors with Tumors without 
      findings for findings for findings for findingsfor 
      antitumor antitumor antitumor antitumor
      effect effect effect effect 
    (1) (2) (3) (4) 
---------------------------------------------------------------------------------------------
I* 0.99±0.25 2.39±0.41 5.70±0.32 4.39±0.43 
II*a` 1.22±0.29 2.45±0.27 4.06±0.72 4.18±0.43 
III*** 2.48±0.44 4.47±0.38
*Mice bearing a small Ehrlich tumor in which stimulated spleen cells 
were transferred. 
"Mice previously treated by transfer of stimulated spleen cells and then 
transplanted with tumor. 
***Tumor-bearing mice untreated by transfer of stimulated spleen cells 
(controls). Values are mean ± SE.
secondary lysosomes were detected (Fig. 4). Other cells 
showed enlarged nuclei with prevailing euchromatin 
and nucleoli with fibrilar centers. Multiple free 
ribosomes were found in the cytoplasm. These cells 
were characterized as actively synthesizing cells, par-
ticularly in protein synthesis (Fig. 5). Cells with ex-
posed ultrastructural features were found in the pre-
served tumor tissue in small tumors of Group I and II 
with findings for a.e., and in tumor without such find-
ings of the same two groups and of Group III. 
 Severe degenerative and necrotic changes in tumor 
cells akin to the irreversible hypoxic injuries were de-
tected in all examined groups. Tumor cells in 
apoptosis in all groups were characterized by conden-
sation and margination of nuclear chromatin, often
Ehrlich tumor of Group I and II with findings for a.e., 
column 1 in Table 1, was lower than the mean MI in 
tumors without finding for effect of the same groups, 
column 2 in Table 1, and in controls (Group III); 
P<0.001. Concerning apoptosis, the mean AI in tumors 
of all groups (I, II and III) exceeded the mean MI; 
P<0.001. The significance of the differences between 
the compared groups was determined by the Mann-
Whitney U test, too (P<0.05). In tumors of Group I and 
II with findings for a.e. a few mitoses in one field (16 
x 40) were counted, however there were fields without 
any mitoses. In tumors of Group I, II without findings 
for a.e. and Group III centers of proliferation with 8-14 
mitoses in the high power field were found, mainly in 
the periphery of the tumor. The number of pathologic 
mitoses was high, at rate of 80.65% of all mitoses. 
Apoptotic cells and numerous apoptotic bodies were 
detected everywhere in tumor tissue. Apoptotic cells 
were found to decrease in size with condensation of 
the eosinophilic cytoplasm, compaction and margination 
of nuclear chromatin. Small apoptotic bodies were in-
gested by tumor cells. Between the cells, spherical 
globules (4-5 ,u m), basophilic, or acidophilic containing 
basophilic nuclear fragments, as well as large globules 
at the size 7-10 um, were observed. Around apoptotic 
bodies, often a clear space (halo) was seen.
Figure 4. Electron micrograph of two tumor cells, one is 
binuclear. Heterochromatin in the nuclei is shown as irregu-
lar blocks. Mitochondria (arrows) are increased in number. 
Original magnification x 3, 500. Ehrlich tumor in a mouse of 
Group II without findings for a.e.
Electron microscopic changes
 In tumor cells, oval, elongated or irregular in shape 
nuclei was observed, with blocks of condensed chro-
matin. In the cytoplasm, mitochondria, increased in 
number, rough endoplasmic reticulum appeared as 
small and tubule-like cisternae, ribosomes and
Figure 5. Electron micrograph of tumor cell with prevail-
ing euchromatin in the large nucleus and big nucleolus (Nc). 
Free ribosomes, vacuoles (V) containing residual bodies and 
two centrioles (Ce) are seen in the cytoplasm. Original magni-
fication x 8,000. Ehrlich tumor in a mouse of Group II with 
findings for a.e.
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Figure 6. Ultrastructural findings for lymphocytic cytotoxicity: A. Two small lymphocytes close to a tumor cell in early 
apoptosis showing margination and condensation of nuclear chromatin (arrows). Vacuoles (V) in the cytoplasm containing resid-
ual material. B. Small lymphocytes with primary lysosomes (Ly), one displaying membrane cell-to-cell contact (arrow) with 
tumor cell in apoptosis, revealing condensation of nuclear chromatin (arrows) and cytoplasm. C. Small lymphocyte contacts 
with cell in advanced apoptosis (A). Original magnifications: in A x 6,000, in B and C x 4,000. Tumor nodule in a mouse of 
Group I with findings for a.e.
forming crescent profile or its compaction as a dense 
masses with irregular outline, and condensation of or-
ganelles of the cytoplasm. Apoptotic bodies containing 
masses of condensed chromatin and sometimes 
cytoplasmic organelles were seen. 
 Small lymphocytes were revealed in the peripheral 
cell infiltrate in tumor nodules of Group I and II with 
findings for a.e., as well as lymphocytes in activation. 
Immunoblasts (stimulated lymphocytes) were also 
found. Evidence for lymphocytic cytotoxicity was de-
tected by electron microscopy (Group I and II with 
findings for a.e.). Small lymphocytes were disposed in 
immediate proximity to apoptotic cells and bodies 
(Fig. 6 A). Cell-to cell contact of lymphocytes with 
tumor cells in apoptosis was found, too (Fig. 6 B, C). 
The contacting lymphocytes contained in the cyto-
plasm primary lysosomes increased in number and
grouped. Infiltration by lymphocytes in tumor nodule 
with the evidence for lymphocytic cytotoxicity was 
observed in some mice 6 days after transfer of stimu-
lated spleen cells but not in mice three to five days 
after this transfer. In tumors of Group I and II with 
findings for a.e., small lymphocytes were detected in 
close proximity to small areas of necrosis.
Changes in the reactive structures of the spleen and 
lymph nodes
 In the spleen of the tumor-bearing mice untreated 
by transfer of stimulated spleen cells (controls), par-
ticularly in the periarterial (T) zone and the B zone of 
the Malpighian bodies lack of reaction, or rarely 
weakly expressed hyperplasia was observed. In some 
lymph nodes in the vicinity of tumors, the
paracortical areas were reacted - 450,u m in transver-
sal size (grade I). Plasmocytes in the lower paracortex 
and in the medullary cords were 25-30% of the total 
number of cells (grade I, PL 1). In more of the mice of 
Group I and II with findings for a.e., reactive changes 
of mixed type, engaging T and B zones, were found in 
the spleens; T,B, and in one - T2B,. Isolated reactive 
changes in T zones (T,) and in B zones (B,) or lack of 
such changes were observed in some cases, too. In T1B,, 
periarterial (T) zones were 250-400,u m of transversal 
dimension, in T2B,- 450-550,u m, and B, zones (germi-
nal centers) - 250-300 am. Small lymphocytes and scanty 
immunoblasts were detected in T zones. Centroblasts, 
centrocytes and macrophages ingested apoptotic bod-
ies were found in the germinal centers. The mantle 
zone was well expressed. In the cords of the red pulp 
lymphocytes, macrophages, plasmocytes and 
megakaryocytes were revealed. The presence of the 
plasmocytes in the pulp was graded as 0 and grade I 
(Plo,1) - 10-20% of plasmocytes. 
 The examined tumor-draining lymph nodes in Group 
I and II with finding for a.e., situated nearby, close to 
the tumor, or in contact with it, displayed reactive 
changes mainly of the type T,B, with paracortex 400-4 
50 um and germinal centers 250-300 gym. Plasmatization 
in the medullary cords was of grade 0 and I (Plo,,), and 
of grade II (P12) - 51-55% plasmocytes. Isolated T, 
hyperplasia was also established. Reactive changes of 
type T1B1, P11 in lymph nodes occurred in areas more 
distant from the tumor i.e. In the axiliary regions 
were detected, too. The paracortex was populated with 
lymphocytes, a few immunoblasts and interdigitating 
cells. Post-capillary venules previously with flattened 
endothelial cells, grade 1 in accordance with Syrj a nen 9' 
or with cuboidal endothelium (grade 2) were found. 
Medullary sinuses contained lymphocytes and macro-
phages. In mice without development of a tumor after 
transplantation, including the case with complete 
tumor regression, reactive changes of type TB, were 
established in the spleens. Lymph nodes found in the 
areas of transplantation showed reactive changes of 
type T1B1, Plt and of type T2 with paracortex 750,u m 
in one case. In the active paracortex, post-capillary 
venules of grade 2 were revealed. 
 Mice of Group I and II without findings for a.e. 
demonstrated changes in the spleen mainly of type 
T1B1, Plo,1, but in others a reaction was absent. Lymph 
nodes situated near the tumor displayed changes of 
T1B1, T1 and of T2 (paracortex 720,u m) in one mouse; 
Plo,1, rarely P12. In the paracortex small lymphocytes 
with various density, a few immunoblasts, interdigitating 
and histiocytic cells, and post-capillary venules of 
grade 1 and 2 were discovered.
Inhibition effect of the culture supernatants obtained 
from spleen cells of mice bearing solid Ehrlich tumor 
  The supernatants of spleen cells from mice bearing 
solid Ehrlich tumor non-stimulated with cancer ex-
tract did not show an IE against migration of Ehrlich 
ascites tumor cells; mean MgI>0.80. On the contrary, 
the supernatants decanted from the samples and the 
wells inhibited Ehrlich-cell migration significantly, 
when the spleen cells were stimulated with Ehrlich 
extract, or with PHA, IL-2 and Ehrlich extract at al-
most equal results received for the two ways of stimu-
lation (Table 2); P<0.001. IE was also appeared when 
spleen cells were enriched with T lymphocytes and 
then stimulated with Ehrlich extract; MgI was 0.64± 
0.03. According to the data of FrRCs, a correlation be-
tween the IE showing production of a factor inhibit-
ing Ehrlich-cell migration from the spleen cells of 
Ehrlich tumor-bearing mice, and the stimulation of 
these cells were found; correlation coefficient (r) =0.61, 
0.60, 0.57. 
 Our preliminary experiments showed that the tumor 
extract, which could be found in a little amount in 
the supernatant containing inhibitory factor (IF), did 
not inhibit itself the migration of Ehrlich ascites cells 
in vitro. Identical results were received for the extract 
of the transplanted sarcoma induced in mice by 20-
methylcholanthrene 5'. 
  Spleen cells obtained from mice treated by transfer 
of stimulated cells showed evidence of production of 
IF without to be stimulated with Ehrlich-tumor ex-
tract in vitro. P<0.05 for Group I, and P<0.001 for 
Group II by comparison with the IE of the super-
natants from unstimulated spleen cells (Table 2). 
Production of this factor was not found in all treated
Table 2. Inhibition of Ehrlich-cell migration by culture super-
natants of spleen cells from mice
MgI of culture supernatants of spleen cells from
Ehrlich-tumor Spleen cells were not Spleen cells were stimulated with 
bearing mice stimulated Ehrlich extract PHA, IL-2 and 
                                                Ehrlich extract
                 0.84±0.05 0.61±0.02 0.62±0.04




Group I* 0.75±0.08 
Group II** 0.68±0.07
*Mice bearing a small Ehrlich tumor in which stimulated spleen cells 
were transferred. 
**Mice previously treated by transfer of stimulated spleen cells and then 
transplanted with tumor. Values are mean ± SE.
mice (MgI- 0.63-0.83) and was not connected with the 
presence of findings for a.e. in the transplanted tu-
mors. 
 In the smears obtained from suspension of spleen 
cells, stimulated with PHA, IL-2 and Ehrlich-tumor ex-
tract, the following proportion of lymphoid cells were 
determined: small lymphocytes (6-7,u m) - 68.1 ± 1.51 %, 
middle-sized lymphocytes (8-10p m) - 20.52±0.45% and 
large lymphoid cells (blasts, immunoblasts) with 
pyroninophilic cytoplasm (18-25," m) - 10.88 ± 0.24%. 
The rate of the lymphoid cells in the smears of spleen 
cells from intact mice was as followed: small lympho-
cytes - 89.20 ± 1.06%, middle-sized lymphocytes - 8.65 ± 
1.12% and large pyroninophilic cells 1.99 ± 0.32%. 
Besides the lymphoid cells, a few plasmocytes and 
macrophages were found in the smears, because the 
suspensions were preliminarily incubated in plastic 
flasks.
Discussion
 Previous investigations have shown that the regres-
sion of localized and disseminated experimental tu-
mors can be effectuated by adoptive transfer of spe-
cifically sensitized lymphoid cells", 11,12.13' In the present 
study an adoptive transfer of spleen cells (lymphocytes) 
stimulated with Ehrlich-tumor extract or with PHA, 
IL-2 and tumor extract in mice-bearers of small trans-
planted Ehrlich tumor (Group I) or in tumor-free mice 
with following transplantation (Group II) was accom-
plished. The stimulation of spleen cells by Ehrlich ex-
tract was in agreement with the report that Ehrlich 
murine tumor may be considered clearly immunogenic 2'. 
 Accentuating on the morphological changes in the 
transplanted solid Ehrlich tumors determined by 
mechanisms leading to blockage of growth and exten-
sion of tumor nodule, we set four criteria for a.e. 
These changes were interpreted together with the 
data for production of IF from the stimulated spleen 
cells. It was found the decrease of the proliferative ac-
tivity in small tumor nodules of Group I and II with 
findings for a.e. in which mean MI was lower than 
this in tumors of the same groups (I and II) but with-
out findings for a.e. and of Group III (Table 1). In this 
respect, it could be speculated on the effect of some 
cytokines: IFN y , TNF a / '9 , TGF p produced by cells 
of the infiltrate in the periphery of tumor, and proba-
bly by tumor cells (TGF i) as antiproliferative agents 
for tumor cells"'. TGF beta precursors were detected 
in Ehrlich ascites cells and in ascitic fluid"). 
 Our results showed an activity of apoptosis, which 
in Groups I, II, and III at the time of killing of the
mice, exceeded the mitotic activity of tumor cells. 
According to data from literature, an influence of 
regulatory genes (oncogenes and oncosuppressor 
genes) as c-myc, bcl-2, p53 and ras could be suggested 
on this issue"'. The connection of the local hypoxia 
with apoptosis was considered, too. Graeber et all" has 
reported that in transplanted tumor highly apoptotic 
regions strongly correlate with hypoxic regions ex-
pressing wild type p53. 
 The cell infiltrate rich in lymphocytes in the periph-
ery of tumor nodules showed an evidence for 
lymphocytic cytotoxicity. Based on the ultrastructural 
findings, it was assumed that T-lymphocytes with 
cytotoxic activity, expressing as was shown elsewhere 
Lyt-2 phenotype"), killed tumor cells by inducing 
apoptosis, particularly through cell-to-cell contact. 
Apoptosis induced by attack of lymphotoxin (TNF 9 ), 
secreted from stimulated T-lymphocytes 18), may be 
suggested in case of presence of the apoptotic bodies 
in the proximity of lymphocytes but without cell-to-
cell contact with tumor cells. Focuses and small areas 
of tumor-cell necrosis nearby the lymphocytic infil-
trate in tumors in Group I and II with findings for a.e. 
were likely connected with the effect of TNF a / n 18,19'. 
The proliferation of fibroblasts among the lympho-
cytes pho-cytes f the infiltrate with formation of collagen fi-
bers, and in this way - a fibrotic capsule, was proba-
bly determined by stimulation of production of 
cytokines- FGFs, TGF 13 20' 2J, released from the cells of 
the infiltrate. Morphological changes for a.e. in trans-
planted solid Ehrlich tumors were also obtained in 
exbreeder ICR mice treated with stimulated spleen 
cells (our unpublished data). 
 The stimulated spleen cells (lymphocytes) from 
Ehrlich-tumor bearing mice were immunologically ac-
tive as they produced IF in the supernatants, sup-
pressing the migration of Ehrlich ascites cells. The IF 
was produced by T-lymphocytes, as the spleen cells 
enriched with T-cells accomplished it. Previously, a 
production of IF was found from spleen cells of mice 
immunized with killed sarcoma cells and from eryth-
rocyte rosette-forming cells, separated from peripheral 
blood mononuclear cells, in patients with gastric and 
breast cancer, when the cells were stimulated with 
tumor extract. Active fractions were isolated from 
crude supernatants in the range of molecular weight 
between 14 000 and 5 800 daltons and lower than 5 
800 5, 6'. In the present study, there were data that the 
stimulation of spleen cells with PHA, IL-2 and Ehrlich 
extract caused an activation, partial blast-
transformation and proliferation of T-lymphocytes. 
The low concentration of IL-2 didn't favor generation 
of LAK cells22'.
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 Our unpublished data showed that a factor with 
cytotoxic effect in vitro"' against Ehrlich ascites cells 
were produced in the supernatants of spleen cells 
from mice in which stimulated spleen cells were trans-
ferred. When these supernatants were added to the 
culture of Ehrlich cells, the rate of viable cells de-
creased, as compared to the rate when supernatants 
from unstimulated spleen cells of tumor-bearing mice 
were used. 
 Indirect data from our investigations suggested that 
the lymphocytes in tumor nodule showing antitumor ef-
fect derived, probably, from the transferred splenocytes, 
containing T-lymphocytes including in activation and 
blast-transformation. The stimulated spleen cells (lym-
phocytes) transferred in mice of Group I and II pene-
trated by normal traffic of recirculation in their lym-
phoid organs (spleen and lymph nodes), as was shown 
elsewhere"', where the lymphocytes propagated by 
clonal proliferation and generated immune reactivity 
in the hosts. In our study it was demonstrated by the 
production of IF (positive MgIs) in the supernatants of 
spleen cells of the immunized mice, mostly from 
Group II. Then the lymphocytes invaded the tumor nod-
ule through small blood vessels of the micro circulatory 
bed, mainly in its periphery, and cytotoxic lympho-
cytes influenced on tumor cells. 
 Histologically, lymphoid infiltrate in the periphery 
of a tumor nodule, containing active lymphocytes was 
detected six days after transfer of stimulated spleen 
cells and endured in mice of Group i and II with find-
ings for a.e. in all time of survival. The lymphocytes 
of the cell infiltrate in tumor increased in number 
through a blast-transformation. The participation of 
NK cells in killing of tumor cells was minimal as in 
the tumor of control mice no findings for lymphocytic 
cytotoxity were revealed. 
 When, in mice treated by transfer of stimulated 
spleen cells both the production of IF and findings for 
lymphocytic cytotoxity in tumor were missing, a defi-
cient propagation and clonal expansion of the immune 
cells (lymphocytes) in the lymphoid organs could be 
assumed. Previously, we have shown that the IF was 
produced from peripheral blood CD4+T-cells 6'. In the 
present experiments, the production of IF (positive 
MgIs) attested to the activity of helper T-cells (L3T4+) 
both in the transferred cells and in the spleen cells of 
the host. The subset of helper T-lymphocytes produc-
ing IF could be suppressed in the spleens of mice. In 
this respect, a development of nonspecific suppressor 
cell population in the spleen of C57BL/6 mice bearing 
solid Ehrlich tumor has been reported". On the other 
hand, the possibility for clonal proliferation of lym-
phocytes with cytotoxic function in the lymphoid
organs could be preserved. 
 Concerning the changes in the spleen, it was sug-
gested that the activation of the reactive structures (T 
and B zones) in mice of Group I and II with findings 
for a.e. could be related to the propagation of immune 
lymphocytes. The reactive changes in lymph nodes 
(Group I and II with findings for a.e.) in the vicinity 
of tumor nodule or close to it were connected with 
the drainage of tumor antigens which was assumed 
also for the control tumor-bearing mice (Group III). 
Infiltration and propagation of the transferred stimu-
lated splenic lymphocytes in lymph nodes particularly 
in these disposed distantly from tumor could be con-
sidered, too. The lack of development of an Ehrlich-
tumor after the transplantation and very rarely its 
complete regression in mice treated by stimulated 
spleen cells, together with the reactive changes in the 
spleens and lymph nodes, might be connected with 
the availability of antitumor immunity in the hosts 
despite the possible objection in this respect. It should 
be noticed that the counterparts of tumor-bearing 
mice untreated by transfer of stimulated spleen cells 
(Group III, controls) showed large tumors developed in 
the same terms of living. 
 In conclusion, we described morphological changes 
in the transplanted solid Ehrlich tumor, which were 
accepted as morphological criteria for a.e. These 
changes were determined by a transfer in tumor-
bearing mice of stimulated spleen cells containing 
immunologically active lymphoid cells, producing IF 
in the supernatants. It was suggested that the trans-
ferred cells rich in lymphocytes, including such in ac-
tivation and blast-transformation, propagated by 
clonal proliferation in the lymphoid organs, particu-
larly in the spleens, in mice of Group I and II, and 
provoked immune reactivity established by the pro-
duction of IF. T-lymphocytes migrated by the circula-
tion in tumor nodules mainly in their periphery, and 
cytotoxic lymphocytes induced apoptosis on tumor 
cells.
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